Acadia Pharmaceuticals Inc (ACAD) Com Stk USD0.0001
0.64%- This stock can be held in a
Stocks and Shares ISASell:$16.32
Buy:$16.33
Change:
$0.27 (1.63%)
$0.27 (1.63%)Market closed | Prices delayed by at least 15 minutes
Sell:$16.32
Buy:$16.33
Change:$0.27 (1.63%)
$0.27 (1.63%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 8 April 2024 | Stephen R. DavisPresident/CEO | Sell Tax related | 8,858 | $17.87 | $158,292.46 | 161,983 |
| 8 April 2024 | Stephen R. DavisPresident/CEO | Sell Tax related | 17,716 | $17.87 | $316,584.92 | 144,267 |
| 8 April 2024 | Brendan TeehanCOO | Sell Tax related | 2,568 | $17.87 | $45,890.16 | 38,796 |
| 8 April 2024 | Mark C SchneyerCFO | Sell Tax related | 2,716 | $17.87 | $48,534.92 | 28,742 |
| 8 April 2024 | James K. (Jim) KiharaChief Accounting Officer | Sell Tax related | 1,028 | $17.87 | $18,370.36 | 13,862 |
| 8 April 2024 | James K. (Jim) KiharaChief Accounting Officer | Sell Tax related | 762 | $17.87 | $13,616.94 | 13,100 |
| 27 March 2024 | Stephen R. DavisPresident/CEO | Sell Tax related | 17,714 | $17.90 | $317,080.60 | 118,842 |
| 27 March 2024 | Brendan TeehanCOO | Sell Tax related | 5,140 | $17.90 | $92,006.00 | 36,340 |
| 27 March 2024 | Mark C SchneyerCFO | Sell Tax related | 5,434 | $17.90 | $97,268.60 | 26,183 |
| 26 February 2024 | Stephen R. DavisPresident/CEO | Sell Tax related | 5,577 | $24.67 | $137,584.59 | 101,890 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 May 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 259,109 | $25.65 | $6,646,145.85 | 39,317,673 |
| 24 May 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 218,171 | $25.27 | $5,513,682.96 | 39,029,686 |
| 14 July 2023 | Stephen R. DavisPresident/CEO | Sell Option/Award related | 100,000 | $30.04 | $3,004,350.00 | 36,695 |
| 23 May 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 116,672 | $25.33 | $2,955,325.09 | 38,736,933 |
| 22 May 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 82,148 | $24.46 | $2,009,372.94 | 38,567,129 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.